Our tests demonstrate that knocking down integrins β1 and β3 with siRNA leads to inhibition of FAK activation and that knocking down FAK with siRNA has a strong antiproliferative effect on GBM cells embedded in fibrin as well as clotted plasma. The gene discussed is PTK2; the disease is glioblastoma.